Costs of QuantiFERON®-TB Gold versus tuberculin skin test in Spanish healthcare workers

Journal of Hospital Infection

Volumn 75, Issue 1, 2010, Pages 52-55

  Linertova R ^a   Alvarez Leon E E ^b   Garcia Perez L ^a,c   Serrano Aguilar, P ^c,d  

^a Canary Islands Foundation for Health and Research (FUNCIS)   (Spain)

^b HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d Canary Islands Health Service   (Spain)

Author keywords

Cost analysis; Healthcare workers; Latent tuberculosis; QuantiFERON

Indexed keywords

GAMMA INTERFERON; ISONIAZID;

ADULT; ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; CYTOKINE RELEASE; FEMALE; HEALTH CARE COST; HOSPITAL PERSONNEL; HUMAN; INTERMETHOD COMPARISON; LATENT TUBERCULOSIS; MALE; SCREENING TEST; SPAIN; TUBERCULIN TEST; COMPARATIVE STUDY; ECONOMICS; HEALTH CARE PERSONNEL; IMMUNOASSAY; MASS SCREENING; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; SKIN TEST;

ADULT; BACTERIOLOGICAL TECHNIQUES; HEALTH CARE COSTS; HEALTH PERSONNEL; HUMANS; IMMUNOASSAY; LATENT TUBERCULOSIS; MALE; MASS SCREENING; SKIN TESTS; SPAIN; TUBERCULIN TEST;

EID: 77951295880     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2009.11.023     Document Type: Article

References (19)

1. Oxlade O., Schwartzman K., Menzies D. Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis. Int J Tuberc Lung Dis 2007, 11:16-26.
2. Cascante J.A., Hueto J. Tuberculosis como enfermedad profesional. An Sist Sanit Navar 2005, 28:S107-S115.
3. Menzies D., Joshi R., Pai M. Risk of tuberculosis infection and disease associated with work in health care settings. Int J Tuberc Lung Dis 2007, 11:593-605.
4. Rullán J.V., Herrera D., Cano R., et al. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis in Spain. Emerg Infect Dis 1996, 2:125-129.
5. Harada N., Higuchi K., Mori T. Assessment of nosocomial transmission of tuberculosis in a psychiatric hospital using a whole blood interferon-gamma assay. Jpn J Infect Dis 2008, 61:415-418.
6. Fica C.A., Cifuentes D.M., Ajenjo H.M.C., et al. Tuberculosis in healthcare workers. Rev Chilena Infectol 2008, 25:243-255.
7. Centers for Disease Control and Prevention Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings. Morb Mortal Wkly Rep 2005, 54(RR17):1-141.
8. Grupo de Trabajo del Área TIR de SEPAR SEPAR guidelines. Guidelines for tuberculosis prevention. Arch Bronconeumol 2002, 38:441-451.
9. Ministerio de Sanidad y Consumo Control de la transmisión nosocomial de la tuberculosis 1995, Secretaría del Plan Nacional sobre el SIDA, Madrid.
10. Dewan P.K., Grinsdale J., Liska S., Wong E., Fallstad R., Kawamura L.M. Feasibility, acceptability, and cost of tuberculosis testing by whole-blood interferon-gamma assay. BMC Infect Dis 2006, 6:47.
11. Pai M., Gokhale K., Joshi R., et al. Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing. J Am Med Assoc 2005, 293:2746-2755.
12. Diel R., Loddenkemper R., Meywald-Walter K., Niemann S., Nienhaus A. Predictive value of a whole-blood IFN-gamma assay for the development of active TB disease. Am J Respir Crit Care Med 2008, 77:1164-1170.
13. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control 2006, National Collaborating Centre for Chronic Conditions, Royal College of Physicians, London.
14. Marra F., Marra C.A., Sadatsafavi M., et al. Cost-effectiveness of a new interferon-based blood assay, QuantiFERON-TB Gold, in screening tuberculosis contacts. Int J Tuberc Lung Dis 2008, 12:1414-1424.
15. de Perio M.A., Tsevat J., Roselle G.A., Kralovic S.M., Eckman M.H. Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers. Arch Intern Med 2009, 169:179-187.
16. Álvarez-León E.E., Espinosa-Vega E., Santana-Rodríguez E., et al. Screening for tuberculosis infection in Spanish healthcare workers: comparison of Quantiferon TB Gold in tube with tuberculin skin test. Infect Control Hosp Epidemiol 2009, 30:876-883.
17. Diel R., Nienhaus A., Loddenkemper R. Cost-effectiveness of interferon-γ release assay screening for latent tuberculosis infection treatment in Germany. Chest 2007, 131:1424-1434.
18. Kowada A., Takahashi O., Shimbo T., Ohde S., Tokuda Y., Fukui T. Cost effectiveness of interferon-gamma release assay for tuberculosis contact screening in Japan. Mol Diagn Ther 2008, 12:235-251.
19. Diel R., Nienhaus A., Lange C., Schaberg T. Cost-optimisation of screening for latent tuberculosis in close contacts. Eur Respir J 2006, 28:35-44.